25.10.2014 Views

Full text PDF - International Policy Network

Full text PDF - International Policy Network

Full text PDF - International Policy Network

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

146 Fighting the Diseases of Poverty<br />

waive VAT on all medicines. VAT is counter-intuitive in the sense<br />

that if one of government’s primary objectives is to have a<br />

healthy and productive workforce, surely it does not want to tax<br />

the sick and vulnerable. The VAT received by government on<br />

pharmaceuticals is relatively insignificant. However sick people<br />

could use the money that would have been spent on VAT for a<br />

number of beneficial alternatives, including food.<br />

According to the latest estimates by the official government<br />

statistical agency, Statistics South Africa (SSA), approximately 26<br />

per cent of the South African labour force is unemployed. If<br />

discouraged work seekers are also included, this figure jumps to<br />

approximately 41 per cent. The consequence of mass<br />

unemployment is that there are large numbers of individuals<br />

that currently live in extreme poverty. Indeed, it is estimated<br />

that there approximately 5 million people in South Africa live on<br />

less than a dollar a day. Therefore, it is not unreasonable to<br />

assume that many of them simply cannot afford to buy even<br />

basic pharmaceutical drugs. While the government claims to<br />

take responsibility for the health care of the indigent, it is<br />

obviously not capable of meeting unlimited demands.<br />

How do we remedy this situation? In the long run, the only<br />

way to increase access to medicines is through increasing the<br />

wealth of the citizens of a country and this is only possible<br />

through economic growth. In the short term, the government<br />

can substantially improve its distribution of drugs by privatising<br />

the distribution process and reduce<br />

waiting times by simply approving drugs that have already been<br />

approved for use in developed countries. Finally, the South<br />

African government’s preferred policy of price controls will not<br />

increase access. On the contrary, it will simply reduce supply by<br />

eroding the incentives of potential suppliers.<br />

Jasson Urbach is a research economist with the Free Market<br />

Foundation (Southern Africa) and assistant director of the health<br />

advocacy group Africa Fighting Malaria.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!